EPAZ News: Epazz’s (OTC: EPAZ) MSHealth Software Platform

New Post Public Reply Private Reply Replies (0) Message Board
trooperstocks
267
EPAZ News: Epazz’s (OTC: EPAZ ) MSHealth Software Platform to Launch a Blockchain HIPAA-Compliant Electronic Medical Marijuana Record Software

CHICAGO, IL, Jan. 28, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – Epazz, Inc. (EPAZ), is pleased to announce that it is developing HIPAA (Health Insurance Portability and Accountability Act of 1996)-compliant electronic medical record software based on its MSHealth software platform using its blockchain storage technology to become a market leader in the U.S. medical marijuana market, which is expected to grow to $8 billion by 2024 according to Global Market Insight.

The software will initially be marketed in Canada. The blockchain storage technology will offer patients the ability to control their data and send it to different health care providers for their medical marijuana prescriptions.

According to Epazz CEO, Shaun Passley, Ph.D., “We are extending our state-of-the-art technology in different vertical markets to maximize its value. We expect to grab a significant market share at the onset as our blockchain storage will change how patients control their medical data. Our advanced blockchain technology provides a competitive edge which will allow us to dramatically grow revenues.”

About Epazz, Inc. (www.epazz.com)

Epazz, Inc., is a leading cloud-based software company that specializes in providing customized cloud applications to the corporate world, higher education institutions and the public sector. Epazz BoxesOS™ v3.0 is the complete business web-based software package for small to midsize businesses, Fortune 500 enterprises, government agencies and higher education institutions. BoxesOS provides many of the web-based applications organizations would otherwise need to purchase separately. Epazz’s other products are DeskFlex™ (hoteling software) and Provitrac™ (an applicant-tracking system).

SAFE HARBOR

This is the “Safe Harbor” statement under the Private Securities Litigation Reform Act of 1995: Certain statements contained in this press release are “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements can generally be identified by the use of forward-looking statements such as “may,” “expect,” “intend,” “estimate,” “anticipate,” “believe” and “continue” (or the negative thereof) or similar terminology. Such forward-looking statements are subject to risks, uncertainties and other factors that could cause actual results to differ materially from future results or those implied by such forward-looking statements. Investors are cautioned that any forward-looking statements are not guarantees of future performance and that actual results may differ materially from those contemplated by such forward-looking statements. Epazz, Inc. assumes no obligation and has no intention of updating these forward-looking statements, and it has no obligation to update or correct information prepared by third parties that is not paid for by Epazz, Inc. Investors are encouraged to review Epazz, Inc.’s public filings on SEC.gov and otcmarkets.com, including its unaudited and audited financial statements and its OTC markets filings, which contain general business information about the company’s operations, results of operations and risks associated with the company and its operations.


For more information, please contact:
Investor Relations
investors@epazz.net
(312) 955-8161
www.epazz.com
Scroll down for more posts ▼

Top 10 Most Recent News Articles

NOTHING NINE's Global Ambitions: Paris Show's Impact

Updated Category News Views 58

Paris: Stage or Launchpad? You’d think walking that catwalk in Paris is the holy grail—fashion's own illustrious red carpet. But when you're Chloe, founder of NOTHING NINE, the real hustle kicks off once the lights dim. On 29th September 2026, this designer brand strutted its stuff at one of the grandest venues, Les Invalides, part of the prestigious Paris Fashion...

Continue Reading
Temu Partners with Recyclia to Drive EPR Compliance Boost

Updated Category News Views 65

Temu and Recyclia: Building a Sustainable Marketplace Get this: Temu, the e-commerce giant you've heard trumpeting about affordable goods like some digital bazaar, is diving deeper into sustainability waters with a partner that knows a thing or two about waste. This time, they've linked up with Recyclia over in Spain. The duo's focus? Helping marketplace sellers meet the...

Continue Reading
Medline's Decade-Long WRAP Partnership: More Than Labels

Updated Category News Views 28

A Decade of Trust and Responsibility Here we go, folks—Medline is toasting 10 years with WRAP, and this ain't just fluffy PR spin. When two big players like these lock arms over responsible manufacturing, it's a signal worth paying attention to, and not just for the ethics alone. Production practices that prioritize transparency and worker rights have ramifications...

Continue Reading
SUNON's Approach to AI-Driven Workspaces Debuted at ORGATEC

Updated Category News Views 68

SUNON's Unique Spin on Future Workspaces The world of workplace solutions is buzzing with ideas on how to blend smart tech with soulful spaces. This year, SUNON is hitting ORGATEC 2026 in Cologne with a bold approach that stitches AI, nature, and circular design right into the fabric of office life. They’re not just setting up shop; they’re promising a peek into a...

Continue Reading
RYBREVANT's Promising Results in HNSCC Treatment

Updated Category News Views 277

Impressive Outcomes for RYBREVANT FASPRO in Head and Neck Cancer Tucked away in the endless cycle of drug trials, a glimmer of hope shines through with new data on RYBREVANT FASPRO in treating head and neck squamous cell carcinoma (HNSCC). This science talk might not rattle the ticker tape directly on NYSE:JNJ, but it has all the makings of a game-changer in the oncology...

Continue Reading
CStone's CS2009: A Leap in Cancer Treatment Validated

Updated Category News Views 43

CStone's Game-Changer: CS2009 in the Spotlight CStone Pharmaceuticals just pulled a rabbit out of a hat at the ESMO 2026 Congress, showcasing the clinical might of their CS2009. This ain't just another hype train, folks. We're talking about a trispecific antibody targeting PD-1, VEGF, and CTLA-4. With data rolled out from over 300 patients, this compound promises a...

Continue Reading
Air Sealing First: Boosting Home Comfort & Efficiency

Updated Category News Views 219

Everyone wants a cozy, energy-efficient home, right? Well, the first step to achieving that might just surprise you. Forget about shoving more insulation into the walls for a second; air sealing should be your starting line. That's the drum Insulation Expert Mike Mancuso is beating, and he's got a point worth considering before you touch another insulation panel. Cracking...

Continue Reading
Artprice Champions Creative Freedom with AI in 2026

Updated Category News Views 78

AI and the Creative Reawakening As the autumn of 2026 rolls in, publishing circles are buzzing over artificial intelligence's role in artistry. Weekly updates hailing rejection, tolerance, or adaptation of AI in writing stir the pot. Yet, Artprice by Artmarket stands out by anchoring creative freedom and responsibility in the spotlight. Grounded on an initiative launched...

Continue Reading
Sirha Lyon® 2027: A New Chapter in Foodservice

Updated Category News Views 54

A Bold Step Forward There's a hearty aroma wafting from Lyon this January, and it's not just from the local gastronomy. Sirha Lyon® is queuing up for its 23rd edition, promising to turn the Foodservice and Hospitality sectors on their heads. Nearly 150,000 square meters of exhibition space packed to the rafters with over 4,300 exhibitors—this ain't your average trade...

Continue Reading
OncoHost's Research Links TKI Sensitivity to Biology

Updated Category News Views 75

Cracking the Code on TKI Sensitivity When it comes to medicine, sometimes the trickiest part is knowing which button to push—especially in the high-stakes world of metastatic renal cell carcinoma (mRCC). OncoHost just dropped a bombshell at the ESMO 2026 Congress about their new plasma proteomics model that lets us peer into what makes some patients click with Tyrosine...

Continue Reading

Top 5 Most Recently Viewed Articles

Palladius Capital Management Expands Portfolio with $579M Investment

Updated Category News Views 325

Palladius Capital Management Expands Its Investment Portfolio Palladius Capital Management, a renowned real estate investment manager, has made significant strides in the residential real estate sector. Recently, they announced the acquisition of nine residential real estate assets valued at $579 million. This impressive portfolio comprises five multifamily properties and...

Continue Reading
Forza X1 Director's Stock Purchase Signals Future Confidence

Updated Category News Views 60

Forza X1 Director Makes a Bold Move with Company Shares In an eye-catching development, Kevin Schuyler, a director at Forza X1, Inc. (NASDAQ:FRZA), has attracted attention with his recent purchase of $27,200 worth of company stock. Schuyler acquired an impressive 90,668 shares at a price of $0.30 each, which brings his total to 100,000 shares, as per the latest filings....

Continue Reading
Whitlock Law's Commitment to Inclusivity at Local Festival

Updated Category News Views 142

Whitlock Law Supports Community Events with Sponsorship Attorney Morgan Whitlock is thrilled to share that her firm, Whitlock Law, has stepped up to sponsor the Loudoun Pride Festival for 2025. As a Gold Sponsor, she has made a significant contribution to the festival, committing over $2,500 to help promote inclusivity and support for the LGBTQ+ community. About the...

Continue Reading
Chaco Launches Nationwide Design Contest for New Sandal Strap

Updated Category News Views 174

Chaco Launches Designapalooza Contest for the Community Get ready for an exciting opportunity to unleash your creativity with Chaco's newest initiative, the Designapalooza contest. This competition invites artists and fans from all backgrounds to contribute their unique designs for a chance to shape the next iconic Z/1 Classic sandal strap. Not only does it encourage...

Continue Reading
Algoma Steel Group Revitalizes Normal Course Issuer Bid

Updated Category News Views 80

Renewal of Algoma Steel Group's Normal Course Issuer Bid Algoma Steel Group Inc. (NASDAQ: ASTL; TSX: ASTL) has revealed its intention to renew its normal course issuer bid (NCIB) for a portion of its common shares and warrants. This initiative is designed to be advantageous for the Company, allowing it to capitalize on fluctuations in market prices. Through this program,...

Continue Reading